News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
635,366 Results
Type
Article (20261)
Company Profile (201)
Press Release (615304)
Multimedia
Podcasts (55)
Webinars (13)
Section
Business (211398)
Career Advice (719)
Deals (31884)
Drug Delivery (48)
Drug Development (64212)
Employer Resources (57)
FDA (13382)
Job Trends (11696)
News (299637)
Policy (23118)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1514)
Accelerated approval (29)
ADA (26)
Adcomms (2)
Allergies (157)
Alliances (47159)
ALS (145)
Alzheimer's disease (1291)
Antibody-drug conjugate (ADC) (408)
Approvals (14077)
Artificial intelligence (698)
ASCO (204)
Autoimmune disease (277)
Automation (61)
Bankruptcy (297)
Best Places to Work (9328)
BIO (51)
BIOSECURE Act (7)
Biosimilars (135)
BioSpace Insights (94)
Biotechnology (137)
Bladder cancer (167)
Brain cancer (50)
Breast cancer (627)
Cancer (4896)
Cardiovascular disease (321)
Career advice (617)
Career pathing (12)
CAR-T (312)
CDC (12)
Celiac Disease (1)
Cell therapy (811)
Cervical cancer (46)
Clinical research (56990)
Collaboration (2039)
Commercialization (2)
Company closure (1)
Compensation (1462)
Complete response letters (39)
COVID-19 (1501)
CRISPR (115)
C-suite (1085)
Cystic fibrosis (112)
Data (7096)
Decentralized trials (2)
Denatured (28)
Depression (122)
Dermatology (75)
Diabetes (452)
Diagnostics (6548)
Digital health (65)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (305)
Drug pricing (24)
Drug shortages (7)
Duchenne muscular dystrophy (199)
Earnings (84127)
Editorial (11)
Employer branding (9)
Employer resources (53)
Events (108366)
Executive appointments (1000)
FDA (16895)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (29)
Funding (1543)
Gene editing (239)
Generative AI (50)
Gene therapy (576)
GLP-1 (499)
Government (1830)
Grass and pollen (4)
Guidances (355)
Healthcare (14427)
Hematology (123)
HIV (71)
Huntington's disease (28)
IgA nephropathy (77)
Immunology and inflammation (138)
Immuno-oncology (71)
Indications (191)
Infectious disease (1780)
Inflammatory bowel disease (161)
Inflation Reduction Act (6)
Influenza (125)
Intellectual property (309)
Interviews (84)
IPO (14968)
IRA (10)
Job creations (2752)
Job search strategy (553)
JPM (22)
Kidney cancer (19)
Labor market (27)
Layoffs (175)
Leadership (8)
Legal (6032)
Licensing (4)
Liver cancer (72)
Longevity (28)
Lung cancer (604)
Lymphoma (345)
Machine learning (56)
Management (20)
Manufacturing (948)
Marketing (9)
MASH (140)
Medical device (13686)
Medtech (13906)
Mergers & acquisitions (18198)
Metabolic disorders (930)
mRNA (191)
Multiple sclerosis (137)
NASH (7)
Neurodegenerative disease (331)
Neuropsychiatric disorders (52)
Neuroscience (2452)
NextGen: Class of 2026 (5049)
Non-profit (2025)
Now hiring (19)
Obesity (303)
Opinion (118)
Ovarian cancer (191)
Pain (209)
Pancreatic cancer (273)
Parkinson's disease (296)
Partnered (24)
Patents (589)
Patient recruitment (680)
Peanut (61)
People (53126)
Pharmaceutical (40)
Pharmacy benefit managers (12)
Phase 1 (18948)
Phase 2 (25398)
Phase 3 (17165)
Pipeline (8874)
Policy (79)
Postmarket research (1729)
Preclinical (8175)
Press Release (69)
Prostate cancer (269)
Psychedelics (10)
Radiopharmaceuticals (314)
Rare diseases (762)
Real estate (4879)
Recruiting (25)
Regulatory (19452)
Reports (22)
Research institute (1578)
Resumes & cover letters (107)
Rett syndrome (45)
RNA editing (18)
RSV (64)
Schizophrenia (117)
Series A (274)
Series B (194)
Service/supplier (5)
Sickle cell disease (76)
Special edition (1)
Spinal muscular atrophy (105)
Sponsored (25)
Startups (3308)
State (2)
Stomach cancer (4)
Supply chain (80)
Tariffs (12)
The Weekly (25)
Vaccines (702)
Venture capital (64)
Weight loss (113)
Women's health (104)
Worklife (4)
Date
Today (116)
Last 7 days (491)
Last 30 days (1699)
Last 365 days (25233)
2026 (15075)
2025 (25199)
2024 (30103)
2023 (34722)
2022 (45177)
2021 (48663)
2020 (45649)
2019 (36378)
2018 (27300)
2017 (27200)
2016 (26234)
2015 (32733)
2014 (27755)
2013 (23737)
2012 (25694)
2011 (26043)
2010 (24896)
Location
Africa (450)
Alabama (87)
Alaska (6)
Arizona (353)
Arkansas (16)
Asia (33517)
Australia (5228)
California (13277)
Canada (3634)
China (1075)
Colorado (583)
Connecticut (523)
Delaware (297)
Europe (63921)
Florida (2009)
Georgia (430)
Hawaii (4)
Idaho (60)
Illinois (1014)
India (81)
Indiana (436)
Iowa (19)
Japan (568)
Kansas (125)
Kentucky (45)
Louisiana (41)
Maine (38)
Maryland (1476)
Massachusetts (9343)
Michigan (392)
Minnesota (739)
Mississippi (6)
Missouri (144)
Montana (31)
Nebraska (19)
Nevada (127)
New Hampshire (89)
New Jersey (3123)
New Mexico (25)
New York (3384)
North Carolina (1619)
North Dakota (10)
Northern California (6578)
Ohio (377)
Oklahoma (22)
Oregon (28)
Pennsylvania (2571)
Puerto Rico (26)
Rhode Island (50)
South America (727)
South Carolina (89)
South Dakota (1)
Southern California (5451)
Tennessee (190)
Texas (2181)
United States (45664)
Utah (415)
Vermont (2)
Virginia (233)
Washington D.C. (52)
Washington State (1078)
West Virginia (3)
Wisconsin (142)
Wyoming (1)
635,366 Results for "emisphere technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
July 22, 2026
·
8 min read
Press Releases
IonQ Completes Acquisition of SkyWater Technology
August 2, 2026
·
6 min read
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Press Releases
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
June 11, 2026
·
5 min read
Press Releases
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
July 8, 2026
·
3 min read
Press Releases
Augurex Named ADLM 2026 Disruptive Technology Award Finalist
• Augurex’s SPINEstat® (Anti-14-3-3eta Multiplex for axial spondyloarthritis) test has been selected as a finalist in the ADLM 2026 Disruptive Technology Award, one of laboratory medicine’s most competitive recognition programs. • Augurex will present at ADLM 2026 on July 27 in Anaheim, CA, with a dedicated finalist kiosk on the Expo Floor July 28–30. • The recognition underscores Augurex’s leadership in developing biomarker-driven diagnostics that address critical unmet needs across autoimmune and inflammatory diseases.
May 28, 2026
·
1 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Expands AI Commercialization Strategy with Enterprise Vision Solutions
May 11, 2026
·
2 min read
Press Releases
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
June 30, 2026
·
7 min read
Press Releases
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
August 4, 2026
·
5 min read
1 of 63,537
Next
